MedTrace Logo

InORS - International Observational Registry on Schizophrenia With Injectable Risperidone and Oral Antipsychotics

NCT01026285 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1085

Last updated 2013-06-24

No results posted yet for this study

Summary

International Observational Registry on Schizophrenia

Conditions

Interventions

DRUG

Risperidone Long-Acting injectable or oral antipsychotics

According to label

Sponsors & Collaborators

  • Janssen-Cilag International NV

    lead INDUSTRY

Principal Investigators

  • Janssen-Cilag International NV Clinical Trial · Janssen-Cilag International NV

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-06-30
Primary Completion
2012-03-31
Completion
2012-03-31

Countries

  • Czechia
  • France
  • Germany
  • Greece
  • Russia
  • South Africa
  • Spain
  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01026285 on ClinicalTrials.gov